Bank of New York Mellon
SRTA

Bank of New York Mellon’s Strata Critical Medical Inc SRTA Stock Holding History

Bank of New York Mellon’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.01M Buy
1,141,035
+62,010
+6% +$326K ﹤0.01% 2332
2026
Q1 		$4.51M Sell
1,079,025
-38,778
-3% -$187K ﹤0.01% 2374
2025
Q4 		$5.38M Sell
1,117,803
-95,176
-8% -$460K ﹤0.01% 2281
2025
Q3 		$6.14M Buy
1,212,979
+1,066,283
+727% +$4.71M ﹤0.01% 2205
2025
Q2 		$591K Buy
146,696
+8,135
+6% +$26.5K ﹤0.01% 3413
2025
Q1 		$378K Hold
138,561
– – ﹤0.01% 3589
2024
Q4 		$589K Buy
138,561
+4,118
+3% +$15.7K ﹤0.01% 3436
2024
Q3 		$395K Sell
134,443
-53,497
-28% -$170K ﹤0.01% 3630
2024
Q2 		$654K Buy
187,940
+26,326
+16% +$87.8K ﹤0.01% 3427
2024
Q1 		$461K Sell
161,614
-11,883
-7% -$36.7K ﹤0.01% 3571
2023
Q4 		$612K Buy
173,497
+778
+0.5% +$2.23K ﹤0.01% 3440
2023
Q3 		$447K Hold
172,719
– – ﹤0.01% 3607
2023
Q2 		$681K Buy
172,719
+1,859
+1% +$5.9K ﹤0.01% 3433
2023
Q1 		$578K Sell
170,860
-2,639
-2% -$10.8K ﹤0.01% 3420
2022
Q4 		$621K Buy
173,499
+4,349
+3% +$18.6K ﹤0.01% 3441
2022
Q3 		$682K Buy
169,150
+15,617
+10% +$80.2K ﹤0.01% 3394
2022
Q2 		$685K Buy
153,533
+136,139
+783% +$983K ﹤0.01% 3406
2022
Q1 		$148K Hold
17,394
– – ﹤0.01% 4328
2021
Q4 		$154K Hold
17,394
– – ﹤0.01% 4340
2021
Q3 		$181K Buy
17,394
+174
+1% +$1.52K ﹤0.01% 4241
2021
Q2 		$181K Buy
+17,220
New +$170K ﹤0.01% 4119

Other funds holding SRTA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Bank of New York Mellon's SRTA Position: Q2 2026 in Review

Bank of New York Mellon increased its Strata Critical Medical Inc (SRTA) stake by 5.7% in Q2 2026, buying an estimated $326K and bringing the position to 1,141,035 shares worth $6.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2332.

Bank of New York Mellon first reported a position in SRTA in Q2 2021 and has held it in 21 quarters since. The position peaked at $6.14M in Q3 2025. 57 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Bank of New York Mellon held 1,141,035 shares of Strata Critical Medical Inc worth $6.01M as of Q2 2026.
  • Bank of New York Mellon bought 62,010 Strata Critical Medical Inc shares in Q2 2026, an estimated $326K.
  • Strata Critical Medical Inc made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2332 holding.
  • Bank of New York Mellon first reported a position in Strata Critical Medical Inc in Q2 2021 and has held it in 21 quarters since.
  • Bank of New York Mellon's Strata Critical Medical Inc position peaked at $6.14M in Q3 2025.
  • 57 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.